Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for treating rhinitis

A composition and drug technology, applied in the directions of drug combination, pharmaceutical formula, plant raw material, etc., can solve the problem of not very obvious effect and so on

Inactive Publication Date: 2013-09-04
李波
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although there is a Chinese patent medicine to treat chronic rhinitis at present, the effect is not very significant

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

experiment example

[0045] 1. Clinical observation

[0046] The treatment group selected capsules of the present invention (prepared according to the method of Example 1) to treat 100 cases of rhinitis, including 50 cases of males and 50 cases of females.

[0047] The control group chose Biyankang Capsules, produced by Beijing Red Sun Pharmaceutical Co., Ltd., to treat 100 cases of rhinitis, including 50 males and 50 females.

[0048] 2. Drug selection

[0049] Treatment group: capsules of the present invention (prepared according to the method of Example 1), treated for three courses of treatment (one course of treatment every 7 days), orally, 0.3g per capsule. Take 2 capsules each time, 3 times a day.

[0050] Control group: Biyankang Capsules, produced by Beijing Red Sun Pharmaceutical Co., Ltd., for three courses of treatment (one course every 7 days), orally, 0.3g per capsule. Take 2 capsules each time, 3 times a day.

[0051] 3. Diagnostic criteria

[0052] ① Nasal congestion: nasal co...

experiment example 2

[0070] Experimental example two, typical case

[0071] Case 1: Wang, male, 45 years old. Suffering from sinusitis for many years. Every time because of staying up late aggravates recurrence, easy to get angry. Private prosecution has a large fire, runny nose, slightly dark purple tongue, thin and white fur on the left chi pulse, floating pulse, right pulse imaginary, normal urine and stool, and normal appetite.

[0072] Diagnosis: sinusitis, after three courses of treatment of taking capsules of the present invention (prepared according to the method of embodiment 1; each serving 2, every day; 7 days a course of treatment), dizziness and headache obviously alleviated, and yellow mucus decreased. Following two courses of consolidation, he was completely cured.

[0073] Case 2: Gao Mou, male, 40 years old. According to the self-report, the nose had alternate nasal congestion several years ago, which caused dizziness and brain swelling, which seriously affected sleep, work an...

Embodiment 1

[0076] Embodiment 1 capsule

[0077] Gentian 20kg Xanthium 35kg Macintosh 30kg

[0078] Fish Brain 10kg, Kansui 17kg, Asarum 15kg

[0079] Melon stalk 17kg, dry alum 20kg, indigo 20kg

[0080] Catechin 20kg Flea Hugh 9kg Trichosanthum 10kg

[0081] Fritillaria 10kg, Curcuma 30kg, Spatholobus 30kg

[0082] Albizia Julibrissin 10kg Bellflower 5kg Peony 9kg

[0083] Vitex 6kg Burdock 9kg Black plum 20kg

[0084] Golden Cherry Seed 10kg, Cuscuta Seed 20kg, Chuan Mutong 10kg.

[0085] The above-mentioned medicine is added into conventional auxiliary materials according to the conventional process to make capsules, and each capsule is filled with 0.3g. Take 2 capsules each time, 3 times a day.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine composition for treating rhinitis, and the composition consists of felwort, cocklebur fruit, flower bud of lily magnolia, pseudosciaena crocea, euphorbia kansui, asarum, muskmelon pedicel, dried alum, indigo naturalis, acacia catechu, manyleaf paris rhizome, radices trichosanthis, thunberg fritillary bulb, Guangdong radix curcumae, caulis spatholobi, albizia flower, platycodon grandiflorum, common hogfenneI root, fructus viticis, burdock, smoked plum, fructus rosae laevigatae, semen cuscutae and caulis clematidis armandii. The medicine composition disclosed by the invention is added with general auxiliary materials according to general technique so as to be prepared into clinically acceptable pellet, capsule, slice, particle, powder, decoction or oral liquid. The medicine composition disclosed by the invention has the effects of clearing heat and toxic materials, removing wind, strengthening exterior and curing nasal obstruction, has remarkable effects for treating nasosinusitis, nasal obstruction, rhinorrhea, ache of forehead, rhinitis, nasosinusitis and anaphylactic rhinitis, and causes no toxic and side effects.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating rhinitis. Background technique [0002] Rhinitis refers to inflammation of the nasal mucosa and submucosal tissues. Manifested as congestion or edema, patients often have nasal congestion, runny nose, nasal itching, throat discomfort, cough and other symptoms. When there is inflammation in the nose, a large amount of nasal mucus can be secreted in the nasal cavity, which can turn yellow due to infection. When it flows through the throat, it can cause coughing, and when the amount of nasal mucus is very large, it can also flow out through the front nostril. The etiology of rhinitis local etiology acute rhinitis recurrent or treatment is not thorough and develops into chronic rhinitis. Long-term intermittent or alternating nasal congestion leads to dizziness and brain swelling, which seriously affects sleep, work and study. Mucopurulent nas...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9066A61P11/02A61P37/08A61K33/06A61K35/60
Inventor 李波
Owner 李波
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com